• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ULTRACLIP DUAL TRIGGER BREAST TISSUE MARKER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ULTRACLIP DUAL TRIGGER BREAST TISSUE MARKER Back to Search Results
Catalog Number UNK ULTRACLIP DT
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Reaction (2414)
Event Date 11/12/2016
Event Type  malfunction  
Manufacturer Narrative
Sakamoto, n., ogawa, y., tsunoda, y., & fukuma, e.(2016).Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (ultraclip) placed in phantoms and patients.The japanese breast cancer society, 24, 585-592.Doi 10.1007/s12282-016-0741-0 no hospital/medical records have been made available to the manufacturer.As the lot number for the device was not provided, a review of the device history records will not be performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported in an article in the japanese breast cancer society titled "evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (ultraclip) placed in phantoms and patients", following mastectomy, during pathologic examination, foreign body reaction was observed.The current patient status was not provided.
 
Manufacturer Narrative
Sakamoto, n., ogawa, y., tsunoda, y., & fukuma, e.(2016).Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (ultraclip) placed in phantoms and patients.The japanese breast cancer society, 24, 585-592.Doi 10.1007/s12282-016-0741-0.Manufacturing review: as the lot number for the device was not provided, a manufacturing review could not be performed.Investigation summary: although the sample was not returned for evaluation, three images were provided for review.The image review demonstrated a high density linear pattern consistent with what appears to be an implanted tissue marker.However, the investigation is inconclusive for patient-device incompatibility as the image review could not confirm a reaction.The definitive root cause could not be determined based upon the available information.It is unknown if patient and/or procedural issues contributed to the reported event.Labeling review: the current ifu (instructions for use) states: indications for use: the ultraclip dual trigger breast tissue marker is intended for use to attach to soft breast tissue at the surgical site during an open surgical breast biopsy or a percutaneous breast biopsy to radiographically mark the location of the biopsy procedure.Warnings: as with any foreign object implanted into the body, potential adverse reactions are possible.It is the responsibility of the physician to evaluate the risk/benefit prior to the use of this device.Potential complications: potential complications of marker placement may consist of hematoma, hemorrhage, infection, adjacent tissue injury and pain.The ultraclip dual trigger breast tissue marker is a sterile, single use device comprised of a disposable introducer, and a metal implantable tissue marker with polyvinyl alcohol (pva).
 
Event Description
It was reported in an article in the japanese breast cancer society titled "evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (ultraclip) placed in phantoms and patients", following mastectomy, during pathologic examination, foreign body reaction was observed.The current patient status was not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRACLIP DUAL TRIGGER BREAST TISSUE MARKER
Type of Device
BREAST TISSUE MARKER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
BARD SHANNON LIMITED
san geronimo industrial park
lot #1, road #3, km 79.7
humacao 00791
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key6917281
MDR Text Key88838410
Report Number2020394-2017-01275
Device Sequence Number1
Product Code NEU
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K042341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/05/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK ULTRACLIP DT
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/01/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-